Global Synthetic Biology in Medical Market Growth (Status and Outlook) 2025-2031

The global Synthetic Biology in Medical market size is predicted to grow from US$ 662 million in 2025 to US$ 806 million in 2031; it is expected to grow at a CAGR of 3.3% from 2025 to 2031.

United States market for Synthetic Biology in Medical is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Synthetic Biology in Medical is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Synthetic Biology in Medical is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Synthetic Biology in Medical players cover Thermo Fisher Scientific, Novozymes, Merck KGaA, Agilent Technologies, Arzeda, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LPI (LP Information)' newest research report, the “Synthetic Biology in Medical Industry Forecast” looks at past sales and reviews total world Synthetic Biology in Medical sales in 2024, providing a comprehensive analysis by region and market sector of projected Synthetic Biology in Medical sales for 2025 through 2031. With Synthetic Biology in Medical sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Synthetic Biology in Medical industry.

This Insight Report provides a comprehensive analysis of the global Synthetic Biology in Medical landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Synthetic Biology in Medical portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Synthetic Biology in Medical market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Synthetic Biology in Medical and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Synthetic Biology in Medical.

This report presents a comprehensive overview, market shares, and growth opportunities of Synthetic Biology in Medical market by product type, application, key players and key regions and countries.

Segmentation by Type:
Genome Engineering
NGS
Cloning and Sequencing

Segmentation by Application:
Drug Discovery And Therapeutics
Pharmaceuticals
Other

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Thermo Fisher Scientific
Novozymes
Merck KGaA
Agilent Technologies
Arzeda
Codexis
Ginkgo Bioworks
Precigen
Genscript Biotech Corp
TeselaGen
Integrated DNA Technologies
Twist Bioscience
New England Biolabs

Please note: The report will take approximately 2 business days to prepare and deliver.